Alpha DNA Investment Management’s Voyager Therapeutics VYGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-57,588
Closed -$536K 251
2024
Q1
$536K Buy
+57,588
New +$536K 0.2% 118